Literature DB >> 8751442

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

J El Khoury1, S E Hickman, C A Thomas, L Cao, S C Silverstein, J D Loike.   

Abstract

A pathological hallmark of Alzheimer's disease is the senile plaque, containing beta-amyloid fibrils, microglia and astrocytes. Beta-amyloid fibrils exert a cytotoxic effect on neurons, and stimulate microglia to produce neurotoxins, such as reactive oxygen species. Mononuclear phagocytes, including microglia, express scavenger receptors that mediate endocytosis of oxidized low-density lipoproteins, and adhesion to glucose-modified extra-cellular matrix proteins. Here we report that class A scavenger receptors mediate adhesion of rodent microglia and human monocytes to beta-amyloid fibril-coated surfaces leading to secretion of reactive oxygen species and cell immobilization. Thus, class A scavenger receptors are potential therapeutic targets in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751442     DOI: 10.1038/382716a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  207 in total

1.  Microglia in Alzheimer's disease and transgenic models. How close the fit?

Authors:  D W Dickson
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  Microglia and the immune pathology of Alzheimer disease.

Authors:  D Giulian
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 3.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.

Authors:  N Platt; S Gordon
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 4.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

Authors:  Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

6.  A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36.

Authors:  Kim Wilkinson; Justin D Boyd; Marcie Glicksman; Kathryn J Moore; Joseph El Khoury
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

7.  Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.

Authors:  Kalliopi Thanopoulou; Apostolia Fragkouli; Fotini Stylianopoulou; Spiros Georgopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

Review 8.  Microglia in Alzheimer's disease.

Authors:  Heela Sarlus; Michael T Heneka
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

Review 9.  Oxidative stress signaling in Alzheimer's disease.

Authors:  B Su; X Wang; A Nunomura; P I Moreira; H-gon Lee; G Perry; M A Smith; X Zhu
Journal:  Curr Alzheimer Res       Date:  2008-12       Impact factor: 3.498

10.  Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.

Authors:  J B Mackic; M Stins; J G McComb; M Calero; J Ghiso; K S Kim; S D Yan; D Stern; A M Schmidt; B Frangione; B V Zlokovic
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.